???global.info.a_carregar???
Ana Catarina Pardal de Matos. 25y, PhD Student, h-index 1 (Scopus). BSc in Biochemistry (2020) and MSc in Applied Pharmacology (2022) from the University of Coimbra. Is now a PhD Student in Molecular and Cellular Biotechnology Applied to Health Sciences (ICBAS/FFUP), hosted at LAVQ/REQUIMTE - Drug Discovery & Development Research Unit (3D Unit), Faculty of Pharmacy of the University of Porto, working in the fields of oncology and pharmacology. She published 3 full papers, 3 conference posters, and 1 conference abstract. Catarina has participated in a project hosted at Center for Neuroscience and Cell Biology and granted by Fundação para a Ciência e a Tecnologia. Catarina is certified in Advanced English (C1) from Cambridge School Portugal.
Read full resume ↓
Identification

Personal identification

Full name
Ana Catarina Pardal de Matos

Citation names

  • Matos, Ana

Author identifiers

Ciência ID
811E-1F7D-89EF
ORCID iD
0000-0002-5330-1005

Email addresses

  • up202211843@edu.icbas.up.pt (Professional)

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese (Mother tongue)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
Education
Degree Classification
2023/01 - 2027
Ongoing
 Biotecnologia Molecular e Celular Aplicada às Ciências da Saúde (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2020/10 - 2022/10
Concluded
 Farmacologia Aplicada (Mestrado)
Universidade de Coimbra Faculdade de Farmácia, Portugal
"Anti-álgicos na resposta terapêutica dos carcinomas da mama, bexiga e próstata: Estudo pré-clínico" (THESIS/DISSERTATION)
 18,1
2017 - 2020/07/15
Concluded
 Bioquímica (Licenciatura)
Universidade de Coimbra Faculdade de Ciencias e Tecnologia, Portugal
 15
Affiliation

Science

Category
Host institution 		Employer
2021/08 - 2021/09 Researcher (Research) Fundação para a Ciência e a Tecnologia, Portugal
Universidade de Coimbra Faculdade de Farmácia, Portugal
2020/08 - 2021/07 Research Trainee (Research) Universidade de Coimbra Faculdade de Medicina, Portugal
Projects

Grant

Designation Funders
2023 - 2025 Beat Therapeutics - Innov-ID, Portugal Ventures 3rd Edition award
Internal Ref
PhD Student Fellow
Ongoing
2023 - 2024 BtoBEAT-TNBC : Establishing lethal combinations with a first-in-class inhibitor of dna damage response against triple-negative breast cancer
111-111-111
PhD Student Fellow
Ongoing
Outputs

Publications

Conference abstract
  1. Matos, Ana; Marques, Inês ; Pires, AS; Abrantes, Ana Margarida; Botelho, Maria Filomena. "A influência dos anestésicos locais na resposta terapêutica dos carcinomas mamários e urológicos - Estudos in vitro". Paper presented in 2a Jornadas e VII Congresso Luso-Brasileiro de Patologia Experimental, 2023.
    Accepted
Conference poster
  1. Isca, Vera M. S.; Bangay, Gabrielle; Matos, Ana; Morais, João; Viana, Ana S.; Reis, Catarina; Pereira-Leite, Catarina; et al. Corresponding author: Rijo, Patrícia. "7a-acetoxy-6ß-hydroxyroyleanone as lead compound: from extraction optimization to hybrid nanoparticles for breast cancer therapy". Paper presented in 9th International Electronic Conference on Medicinal Chemistry, 2023.
  2. Matos, Ana; Marques, IA; Pires, AS; Valentim, A; Abrantes, AM; Botelho, MF. Corresponding author: Matos, Ana. "Can anesthetics influence the therapeutic response of breast and urological cancers? An in vitro study". Paper presented in 5th ASPIC International Congress, 2022.
  3. Matos, AC; Marques, IA; Pires, AS; Dias, AL; Valentim, A; Abrantes, AM; Botelho, MF. "Evaluation of the cytotoxic potential of local anaesthetics in breast, bladder and prostate tumour cells". Paper presented in II ASPIC-ASEICA International Meeting - Current Trends in Precision Medicine in Cancer, 2021.
  4. Dias, AL; Marques, IA; Pires, AS; Matos, AC; Laranjo, M; Abrantes, AM; Tavares-Da-Silva, E; Botelho, MF. Corresponding author: Dias, AL. "Evaluation of the anticancer activity of cinnamic acid derivatives targeting COX-2". Paper presented in II ASPIC-ASEICA International Meeting - Current Trends in Precision Medicine in Cancer, 2021.
Journal article
  1. Ana Catarina Matos; João Lorigo; Inês Marques; Ana M Abrantes; Matilde Jóia-Gomes; Sa Couto P; Sa Couto PM; Ana Cristina Gonçalves; et al. "Anti-Algics in the Therapeutic Response of Breast and Urological Cancers". International Journal of Molecular Sciences (2023): http://dx.doi.org/10.3390/ijms25010468.
    10.3390/ijms25010468
  2. Juliana Calheiros; Liliana Raimundo; João Morais; Ana Catarina Matos; Sonia Anna Minuzzo; Stefano Indraccolo; Emília Sousa; Marta Correia da Silva; Lucília Saraiva. "Antitumor Activity of the Xanthonoside XGAc in Triple-Negative Breast, Ovarian and Pancreatic Cancer by Inhibiting DNA Repair". Cancers (2023): https://doi.org/10.3390/cancers15245718.
    10.3390/cancers15245718
  3. Ana Catarina Matos; Inês Marques; Pires AS; Ana Valentim; Ana M Abrantes; MF Botelho. "The Potential Effect of Lidocaine, Ropivacaine, Levobupivacaine and Morphine on Breast Cancer Pre-Clinical Models: A Systematic Review". International Journal of Molecular Sciences (2022): https://www.mdpi.com/1422-0067/23/3/1894.
    10.3390/ijms23031894
Distinctions

Other distinction

2021 Research Grant
Fundação para a Ciência e a Tecnologia, Portugal